WHO Approves Ensifentrine as Name for Potential Inhaled Treatment Now in Clinical Trials
The World Health Organization (WHO) approved ensifentrine as the recommended name to identify the cystic fibrosis (CF) treatment...
Bacterial immunity and infectious disease
Patients with cystic fibrosis are often infected by pseudomonas aeruginosa, a bacterium that infects the lungs and prevents breathing,...
Inhalable RNA could breathe new life into lung cancer treatments
Lung epithelial cells that have taken up the mRNA particles (yellow dots), which makes them glow green(Credit: Asha Patel) In the body,...
Online Program Educates Clinicians Treating MS About Common Comorbidities & Current & New Tr
(MENAFN - PRLog) eMultipleSclerosis Review® Volume 2 launches with new design eMultipleSclerosis Review Spread the Word Listed Under Tag:...
Vertex to Request Review of Orkambi, Symkevi Plus Kalydeco for Public Funding in Scotland
Vertex Pharmaceuticals has announced its intention to submit an application to the Scottish Medicines Consortium (SMC) to review the...
Early detection: Chemists discover new signatures to identify cystic fibrosis in infants sooner with
Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more...
Gene Expression Patterns in Blood May Lead to Patient-tailored CF Treatment, Study Finds
Researchers tested blood samples from cystic fibrosis (CF) patients and identified distinct gene expression patterns that could lead to...
Proteostasis Therapeutics Provides Clinical Enrollment Update
BOSTON, Dec. 20, 2018 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated...
Aridis Enrolling CF Patients to Test AR-501 in Chronic Lung Infections
Aridis Pharmaceuticals has enrolled the first healthy participant in its Phase 1/2a clinical trial to evaluate the antibacterial...
Specific Sweat Test Better Detects Kalydeco’s Effects on CFTR Function, Study Suggests
The effects of CFTR modulator therapies such as Kalydeco (ivacaftor) can be more reliably assessed using a test that specifically...
